Keyphrases
Graft-versus-host Disease (GvHD)
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
33%
Acute Myeloid Leukemia
29%
Myelodysplastic Syndrome
18%
Confidence Interval
15%
Phase II Trial
12%
Decitabine
12%
National Institutes of Health
10%
Overall Survival
10%
Hematopoietic Cell Transplantation
10%
Azacitidine
9%
Bronchiolitis Obliterans Syndrome
9%
Randomized Phase II Trial
9%
Clinical Trials
9%
Ibrutinib
9%
Granulocyte Colony-stimulating Factor (G-CSF)
9%
Failure-free Survival
8%
High Risk
8%
Partial Response
8%
Non-relapse Mortality
8%
Complete Response
7%
Prednisone
7%
COVID-19
7%
Transplantation
7%
Bone Marrow Plasma Cells
6%
Cardio-oncology
6%
National Institutes of Health Consensus
6%
Leukemia
6%
Initial Treatment
6%
Unrelated Hematopoietic Stem Cell Transplantation
6%
Ruxolitinib
6%
Chronic Myeloid Leukemia
6%
Late Acute
6%
B Cell Response
6%
Natural Killer Cells
6%
Group Reports
6%
Consensus Development
6%
Treatment Response
6%
Reduced-intensity Conditioning
5%
Unrelated Donor
5%
Stem Cell Mobilization
5%
Bone Marrow
5%
Cyclophosphamide
5%
Conditioning Regimen
5%
Cell Therapy
5%
Cytomegalovirus Reactivation
5%
Health Response
5%
Medicine and Dentistry
Chronic Graft Versus Host Disease
43%
Hematopoietic Cell
26%
Acute Myeloid Leukemia
23%
Cell Transplantation
18%
Acute Graft Versus Host Disease
16%
Graft Versus Host Reaction
16%
Myelodysplastic Syndrome
12%
Clinical Trial
11%
Biological Marker
10%
Treatment Response
9%
Bronchiolitis Obliterans
9%
Azacitidine
9%
Decitabine
9%
Ibrutinib
9%
Diseases
9%
Infection
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Overall Survival
7%
Clinician
7%
Allogeneic Stem Cell Transplantation
7%
Oncology
6%
Failure Free Survival
6%
Chronic Myelogenous Leukemia
6%
Receptor
6%
Plerixafor
6%
Leukemia
5%
Cancer Therapy
5%
Lung
5%
Myeloid Leukemia
5%
Immunology and Microbiology
Chronic Graft Versus Host Disease
51%
Graft-Versus-Host Disease
35%
Hematopoietic Cell
31%
Cell Transplantation
28%
Acute Graft Versus Host Disease
17%
Myeloid
11%
Bronchiolitis
10%
Conditioning
9%
Prednisone
8%
Overall Survival
8%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Failure Free Survival
7%
Cytomegalovirus
6%
Cyclophosphamide
6%
Blood Plasma
6%
Hematopoietic Stem Cell Transplantation
6%
Spike
6%
B Cell
6%
Natural Killer Cell
6%
Stem Cell Transplantation
6%
Engraftment
5%
Stem Cell
5%
Granulocyte Colony-Stimulating Factor
5%
Colony Stimulating Factor 1 Receptor
5%
